Skip to main content

Boulding Mark Elliott's Form 4 filing

PTC Therapeutics, Inc. (PTCT) · filed Jul 8, 2026

Accession no.
0001578852-26-000020
Filed
Jul 8, 2026, 5:20 PM ET
Trade date
Jul 6, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $432.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Boulding Mark ElliottCIK 0001578852Officer (EXEC. VP AND CLO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 6, 2026Common StockMOption exerciseAcquired+2,266$39.42+$89,325.72107,538Direct
Jul 6, 2026Common StockSSaleDisposed−313$83.10F2−$26,010.3107,225Direct
Jul 6, 2026Common StockSSaleDisposed−833$84.41F3−$70,313.53106,392Direct
Jul 6, 2026Common StockSSaleDisposed−519$85.84F4−$44,550.96105,873Direct
Jul 6, 2026Common StockSSaleDisposed−601$86.38F5−$51,914.38105,272Direct
Jul 6, 2026Common StockMOption exerciseAcquired+2,813$46.54+$130,917.02108,085Direct
Jul 6, 2026Common StockSSaleDisposed−387$83.10F2−$32,159.7107,698Direct
Jul 6, 2026Common StockSSaleDisposed−1,036$84.41F3−$87,448.76106,662Direct
Jul 6, 2026Common StockSSaleDisposed−645$85.84F4−$55,366.8106,017Direct
Jul 6, 2026Common StockSSaleDisposed−745$86.38F5−$64,353.1105,272Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 6, 2026Common StockMOption exerciseDisposed−2,266$0.00$04,532Direct
Jul 6, 2026Common StockMOption exerciseDisposed−2,813$0.00$028,125Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.76 to $83.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 2 transactions in Table I.

F3

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.98 to $84.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 2 transactions in Table I.

F4

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.18 to $86.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 2 transactions in Table I.

F5

This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.18 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)